These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7630675)

  • 41. Cost-effectiveness of an intervention to increase cancer screening in primary care settings.
    Chirikos TN; Christman LK; Hunter S; Roetzheim RG
    Prev Med; 2004 Aug; 39(2):230-8. PubMed ID: 15226030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenges to implementing the current pediatric cholesterol screening guidelines into practice.
    Dennison BA; Jenkins PL; Pearson TA
    Pediatrics; 1994 Sep; 94(3):296-302. PubMed ID: 8065853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulations for implementing the Clinical Laboratory Improvement Amendments of 1988: a summary.
    MMWR Recomm Rep; 1992 Feb; 41(RR-2):1-17. PubMed ID: 1538689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burdensome CLIA regulations: methodology of survey.
    Rappo PD
    Clin Pediatr (Phila); 1996 Nov; 35(11):605. PubMed ID: 8953137
    [No Abstract]   [Full Text] [Related]  

  • 45. The impact of office cholesterol testing.
    Franks P; Engerman J
    J Fam Pract; 1991 May; 32(5):493-6. PubMed ID: 2022937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Federal proficiency testing requirements set to start for physician office laboratories.
    Goldsmith MF
    JAMA; 1989 Nov; 262(17):2355-6. PubMed ID: 2795815
    [No Abstract]   [Full Text] [Related]  

  • 47. Near-patient testing for serum cholesterol: attitudes of general practitioners and patients, appropriateness, and costs.
    Cohen J; Piterman L; McCall LM; Segal L
    Med J Aust; 1998 Jun; 168(12):605-9. PubMed ID: 9673622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of CLIA '88 on the physician office laboratory: a survey of midsized pediatric practices before and after CLIA '88.
    Benjamin JT
    Clin Pediatr (Phila); 1996 Mar; 35(3):125-8. PubMed ID: 8904485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory considerations in the establishment and expansion of office-based laboratories.
    Crane SC
    Med Clin North Am; 1987 Jul; 71(4):733-49. PubMed ID: 3295423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are physicians' office laboratory results of comparable quality to those produced in other laboratory settings?
    Hurst J; Nickel K; Hilborne LH
    JAMA; 1998 Feb; 279(6):468-71. PubMed ID: 9466642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvement in physician's office laboratory practices, 1989-1994.
    St John TM; Lipman HB; Krolak JM; Hearn TL
    Arch Pathol Lab Med; 2000 Jul; 124(7):1066-73. PubMed ID: 10888785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous improvement, quality control, and cost containment in clinical laboratory testing. Effects of establishing and implementing guidelines for preoperative tests.
    Nardella A; Pechet L; Snyder LM
    Arch Pathol Lab Med; 1995 Jun; 119(6):518-22. PubMed ID: 7605167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolution beyond the shared services model of consolidated hospital clinical laboratories.
    Fattal GA; Tanasijevic MJ; Winkelman JW
    Arch Pathol Lab Med; 1995 Aug; 119(8):701-5. PubMed ID: 7646326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal study of error prevalence in Pennsylvania physicians' office laboratories.
    Bloch MJ; Cembrowski GS; Lembesis GJ
    JAMA; 1988 Jul; 260(2):230-5. PubMed ID: 2455071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of time and practice resources required to provide weekly or monthly erythropoiesis-stimulating protein therapy to chronic kidney disease patients in the physician office setting.
    Bernardo M; Crawford P; Hertel J; Sholer C; Xu X; Goss T; Kewalramani R; Globe D
    J Manag Care Pharm; 2006; 12(9):714-25. PubMed ID: 17249904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory and legal influences on physicians' office laboratories.
    Wildermann RF; Schneider KA
    JAMA; 1986 Jul; 256(2):252-3. PubMed ID: 3723712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Will you be able to do office lab tests under CLIA? One last chance to change better-but-still-bad regulations!
    Griffin GC
    Postgrad Med; 1992 Apr; 91(5):25-8, 31-2, 35-8 passim. PubMed ID: 1561164
    [No Abstract]   [Full Text] [Related]  

  • 59. The office laboratory director's guide.
    Fischer P; Addison LA
    JAMA; 1985 Nov 22-29; 254(20):2941-5. PubMed ID: 4057516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimating the cost of developmental and behavioral screening of preschool children in general pediatric practice.
    Dobrez D; Sasso AL; Holl J; Shalowitz M; Leon S; Budetti P
    Pediatrics; 2001 Oct; 108(4):913-22. PubMed ID: 11581444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.